| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |